A new non-invasive method to assess cardiovascular risks in type 2 diabetic patients and the correlation to treatment types

Not Applicable

• Conditions: Type 2 diabetes mellitus; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN50136555
• Lead Sponsor: Melk General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-10-25
• Last Update Posted: 15 March 2021
• Study Completion: 2021-11-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

1. Type 2 diabetic patients
2. Aged between 18 and 70 years
3. Moderate to high cardiovascular risk factors
4. Routinely attend the diabetes outpatients service of the Department of Internal Medicine in the Hospital of Melk
5. Patients will be included independently of their medication

Exclusion Criteria

Patients with dark skin, patients with skin diseases and the use of skin creams, such as agents used to tan” or brown” the skin, cannot be included in the study because of limitations to the autofluorescence measurement, which is adjusted to healthy white skin and may give inadequate results in dark skin.

Study & Design

• Study Type: Observational
• Study Design: Not specified